[
  {
    "date": "2023-12-30",
    "symbol": "TARA",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 39586000,
    "marketablesecuritiescurrent": 25994000,
    "prepaidexpenseandotherassetscurrent": 3125000,
    "assetscurrent": 68705000,
    "restrictedcashnoncurrent": 745000,
    "propertyplantandequipmentnet": 1296000,
    "operatingleaserightofuseasset": 5264000,
    "otherassets": 2944000,
    "assets": 78954000,
    "accountspayablecurrent": 2434000,
    "accruedliabilitiescurrent": 2732000,
    "operatingleaseliabilitycurrent": 983000,
    "liabilitiescurrent": 6149000,
    "operatingleaseliabilitynoncurrent": 4484000,
    "liabilities": 10633000,
    "commonstockvalue": 11000,
    "additionalpaidincapital": 268725000,
    "retainedearningsaccumulateddeficit": -200384000,
    "accumulatedothercomprehensiveincomelossnetoftax": -31000,
    "stockholdersequity": 68321000,
    "liabilitiesandstockholdersequity": 78954000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000000,
    "preferredstocksharesissued": 7991,
    "preferredstocksharesoutstanding": 7991,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 11364903,
    "commonstocksharesoutstanding": 11364903,
    "researchanddevelopmentexpense": 24989000,
    "generalandadministrativeexpense": 18624000,
    "goodwillimpairmentloss": 29500000,
    "operatingexpenses": 43613000,
    "operatingincomeloss": -43613000,
    "investmentincomeinterest": 3193000,
    "nonoperatingincomeexpense": 3193000,
    "netincomeloss": -40420000,
    "earningspersharebasic": -3.57,
    "weightedaveragenumberofsharesoutstandingbasic": 11331338,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": 657000,
    "othercomprehensiveincomelossnetoftax": 657000,
    "comprehensiveincomenetoftax": -39763000,
    "earningspersharediluted": -3.57,
    "weightedaveragenumberofdilutedsharesoutstanding": 11331338,
    "sharesoutstanding": 7991,
    "settlementofrestrictedstockunits": -91000,
    "settlementofrestrictedstockunitinshares": 61691,
    "stockissuedduringperiodvaluerestrictedstockunits": 1208000,
    "stockissuedduringperiodvaluesharebasedcompensation": 4884000,
    "conversionofstocksharesconverted1": -36,
    "sharebasedcompensation": 6092000,
    "operatingleaserightofuseassetamortizationexpense": 1013000,
    "depreciation": 341000,
    "amortizationofdiscountsandpremiumsinvestments": -444000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 1265000,
    "increasedecreaseinotheroperatingassets": 2300000,
    "increasedecreaseinaccountspayable": 848000,
    "increasedecreaseinaccruedliabilities": -505000,
    "increasedecreaseinotheroperatingliabilities": -917000,
    "netcashprovidedbyusedinoperatingactivities": -37557000,
    "paymentstoacquiremarketablesecurities": 12186000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 65338000,
    "paymentstoacquirepropertyplantandequipment": 45000,
    "netcashprovidedbyusedininvestingactivities": 53107000,
    "paymentsforrepurchaseofcommonstock": 91000,
    "netcashprovidedbyusedinfinancingactivities": -91000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 15459000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 40331000,
    "marketabledebtsecuritiespolicytextblock": "MarketableDebt Securities",
    "patentcostspolicytextblock": "PatentCosts",
    "scheduleofestimatedusefullivesforsignificantpropertyandequipmenttabletextblock": "Theestimated useful lives for significant property and equipment categories are as follows:",
    "scheduleofgoodwillandaccumulatedimpairmentlosssestabletextblock": "Thefollowing table provides a roll forward of the Company’s goodwill and accumulated impairment losses:",
    "scheduleofotherinformationrelatedtoleasestabletextblock": "Theweighted average remaining lease term and the weighted average discount rate for operating leases were:",
    "propertyplantandequipmentusefullife": "P3Y",
    "shorteroftheusefullifeofassetortheleaseterm": "Shorter of the useful life of asset or the lease term",
    "moneymarketfundsatcarryingvalue": 39031000,
    "restrictedcashandinvestments": 745000,
    "marketablesecurities": 23495000,
    "agencybonds": 2499000,
    "assetsfairvaluedisclosure": 39776000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 23525000,
    "unrealizedlosses": -30000,
    "estimatedfairvalue": 23495000,
    "interestincomeother": 2727000,
    "investmentincomenetamortizationofdiscountandpremium": 454000,
    "dividendincomeoperating": 12000,
    "prepaidresearchanddevelopment": 1957000,
    "prepaidinsurance": 659000,
    "accruedinterestonmarketabledebtsecurities": 242000,
    "otherprepaidexpensecurrent": 163000,
    "prepaidsoftware": 67000,
    "otherassetscurrent": 37000,
    "propertyplantandequipmentgross": 247000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 824000,
    "prepaidresearchanddevelopmentnoncurrent": 2661000,
    "prepaidinsurancenoncurrent": 272000,
    "otherassetsnoncurrent": 11000,
    "accruedemployeerelatedcurrent": 2112000,
    "accruedresearchanddevelopmentcurrent": 440000,
    "otheraccruedliabilitiescurrent": 180000,
    "operatingleasecost": 1423000,
    "leasecost": 1423000,
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "operatingleaseweightedaverageremainingleaseterm1": "P55M",
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1395000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1429000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1429000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 718000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 87000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6385000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 918000,
    "operatingleaseliability": 5467000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 236679,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 7.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 165100,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.02,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 30731,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 4.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 94528,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 12.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 1.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0346,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 2900205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 9.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 2900205,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 9.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 1242111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 15.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1310900,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 157523,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 6.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 81501,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 15.94,
    "restrictedstockexpense": 1208000,
    "stockoptionplanexpense": 4884000,
    "allocatedsharebasedcompensationexpense": 6092000,
    "deferredfederalincometaxexpensebenefit": -9627000,
    "deferredstateandlocalincometaxexpensebenefit": -4124000,
    "deferredincometaxexpensebenefit": -13751000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 13751000,
    "deferredtaxassetsoperatinglosscarryforwards": 30731000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 9611000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4464000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 4824000,
    "deferredtaxassetsoperatingleaseliability": 1485000,
    "deferredtaxassetsrestrictedstockunitsexpense": 2723000,
    "deferredtaxassetsother": 467000,
    "deferredtaxassetsgross": 54305000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsreturnsandallowances": 52734000,
    "deferredtaxassetsnet": 1571000,
    "deferredtaxliabilitiesoperatingrightofuseasset": 1430000,
    "deferredtaxliabilitiesother": -141000,
    "deferredincometaxliabilities": 1571000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.078,
    "effectiveincometaxratereconciliationotheradjustments": 0.04,
    "effectiveincometaxratereconciliationtaxcreditsresearch": 0.024,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.022,
    "effectiveincometaxratereconciliationsharebasedcompensationcost": -0.013,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.004,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.339,
    "netincomelossavailabletocommonstockholdersbasic": -40420000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 2900205,
    "vestingperiod": "P1Y",
    "stockoptionperiod": "P4Y",
    "percentageoflargestamountofbenefit": 0.5,
    "percentageofpropertyandequipment": 1,
    "areaofland": 10300,
    "paymentsforrent": 1117000,
    "operatingleasepayments": 1234000,
    "royaltyexpenselowerrange": 25000,
    "royaltyexpenseupperrange": 75000,
    "upperlimitofadditionalmilestonepayments": 775000,
    "commonstockvotingrights": "one",
    "preferredstockconvertibleconversionratio": 1000,
    "preferredstockconvertibleconversionprice": 7.01,
    "preferredstockconversionlimit1": 0.0999,
    "preferredstockconversionlimit2": 0.1999,
    "preferredstockliquidationpreference": 10,
    "preferredsharesredeemedduringconversion": 36,
    "commonsharesissuedduringconversion": 35823,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 191000,
    "numberofsharesincreasedecreasedescription": "The number of shares increases each January 1, commencing on January 1, 2015 and ending on (and including)January 1, 2024, by an amount equal to the lesser of one percent of the outstanding shares as of the end of the immediately precedingfiscal year, 7,025 shares or any lower amount determined by the Company’s Board of Directors prior to each such January 1st.",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 569000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y6M18D",
    "numberofrestrictedstockvestedunsettled": 289500,
    "numberofrsussettled": 94528,
    "connectionwiththenetsharesettlement": 91000,
    "effectiveincometaxratereconciliationatfederalincometaxratepercent": 0.21,
    "apportionmentschangespercentage": 0.04,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 187492,
    "incometaxcarriedforwardterms": "P20Y",
    "deferredtaxassetsothertaxcarryforwards": 600000,
    "deferredtaxassetsvaluationallowance": 52700000,
    "definedcontributionplanemployermatchingcontributionpercentofmatch": 1,
    "definedcontributionplanemployermatchingcontributionpercent": 0.04,
    "definedcontributionplanemployerdiscretionarycontributionamount": 237000,
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityinteractivedatacurrent": "Yes",
    "icfrauditorattestationflag": "false",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityregistrantname": "Protara Therapeutics, Inc.",
    "entitycentralindexkey": 1359931,
    "entityfilenumber": "001-36694",
    "entitytaxidentificationnumber": "20-4580525",
    "entityincorporationstatecountrycode": "DE",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityshellcompany": "false",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityaddressaddressline1": "345 Park Avenue South",
    "entityaddressaddressline2": "3rd Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(646)",
    "localphonenumber": "844-0337",
    "security12btitle": "common stock, par value $0.001 per share",
    "tradingsymbol": "TARA",
    "securityexchangename": "NASDAQ",
    "auditorname": "Ernst & Young LLP",
    "auditorfirmid": 42,
    "auditorlocation": "New York, New York"
  },
  {
    "date": "2022-12-30",
    "symbol": "TARA",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 24127000,
    "marketablesecuritiescurrent": 60243000,
    "prepaidexpenseandotherassetscurrent": 1776000,
    "assetscurrent": 86146000,
    "restrictedcashnoncurrent": 745000,
    "marketablesecuritiesnoncurrent": 17886000,
    "propertyplantandequipmentnet": 1592000,
    "operatingleaserightofuseasset": 6277000,
    "otherassetsnoncurrent": 644000,
    "assets": 113290000,
    "accountspayablecurrent": 1586000,
    "accruedliabilitiescurrent": 3237000,
    "operatingleaseliabilitycurrent": 917000,
    "liabilitiescurrent": 5740000,
    "operatingleaseliabilitynoncurrent": 5467000,
    "liabilities": 11207000,
    "commonstockvalue": 11000,
    "additionalpaidincapital": 262724000,
    "retainedearningsaccumulateddeficit": -159964000,
    "accumulatedothercomprehensiveincomelossnetoftax": -688000,
    "stockholdersequity": -688000,
    "liabilitiesandstockholdersequity": 113290000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 8028,
    "preferredstocksharesissued": 8027,
    "preferredstocksharesoutstanding": 8027,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 31658,
    "commonstocksharesoutstanding": 48806,
    "researchanddevelopmentexpense": 16808000,
    "generalandadministrativeexpense": 20737000,
    "goodwillimpairmentloss": 29500000,
    "operatingexpenses": 67062000,
    "operatingincomeloss": -67062000,
    "investmentincomeinterest": 1110000,
    "nonoperatingincomeexpense": 1110000,
    "netincomeloss": -65952000,
    "earningspersharebasic": -5.86,
    "weightedaveragenumberofdilutedsharesoutstanding": 11259615,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -477000,
    "othercomprehensiveincomelossnetoftax": -477000,
    "comprehensiveincomenetoftax": -66429000,
    "earningspersharediluted": -5.86,
    "sharesoutstanding": 11267389,
    "settlementofrestrictedstockunits": -90000,
    "settlementofrestrictedstockunitinshares": 31658,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1273000,
    "stockissuedduringperiodvaluesharebasedcompensation": 5415000,
    "othercomprehensiveincomelossbeforetax": -477000,
    "sharebasedcompensation": 5177000,
    "operatingleaserightofuseassetamortizationexpense": 1366000,
    "depreciation": 110000,
    "amortizationofdiscountsandpremiumsinvestments": 1137000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -265000,
    "increasedecreaseinotheroperatingassets": -222000,
    "increasedecreaseinaccountspayable": 631000,
    "increasedecreaseinaccruedliabilities": 748000,
    "increasedecreaseinotheroperatingliabilities": -1327000,
    "netcashprovidedbyusedinoperatingactivities": -26457000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 43550000,
    "proceedsfrommaturityandredemptionofmarketabledebtsecurities": 58620000,
    "paymentstoacquirepropertyplantandequipment": 120000,
    "netcashprovidedbyusedininvestingactivities": 14950000,
    "paymentsforrepurchaseofcommonstock": 90000,
    "netcashprovidedbyusedinfinancingactivities": -90000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -11597000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 24872000,
    "marketabledebtsecuritiestextblock": "4. Marketable Debt Securities ",
    "marketabledebtsecuritiespolicytextblock": "Marketable Debt Securities ",
    "patentcostspolicytextblock": "Patent Costs ",
    "recentaccountingpronouncementsnotyetadopted": "Recent Accounting PronouncementsNot Yet Adopted ",
    "scheduleofestimatedusefullivesforsignificantpropertyandequipmenttabletextblock": "      Asset    Classification         Estimated    Useful Life      Computer    equipment         5      Furniture,    fixtures and other         5      Laboratory    equipment         7      Leasehold    improvements         Shorter of the useful life of asset or the lease term    ",
    "scheduleofgoodwillandaccumulatedimpairmentlosssestabletextblock": "            Goodwill       Goodwill, gross amount as of December 31, 2021     $29,517       Accumulated impairment loss, as of December 31, 2021      -       Goodwill as of December 31, 2021      29,517       Additions to goodwill      -       Loss on impairment      (29,517)      Goodwill as of December 31, 2022     $-    ",
    "scheduleofinterestandinvestmentincometabletextblock": "            December 31,             2022      2021       Interest income     $2,230      $1,974       Accretion/(amortization) of discount/premium, net      (1,137)      (1,737)      Realized gain/(loss)      17       -       Total interest and investment income     $1,110      $237   ",
    "scheduleofotherinformationrelatedtoleasestabletextblock": "            For the year ended December 31,             2022      2021                            Weighted-average discount rate      7.0%      7.0%      Weighted-average remaining lease term – operating lease (in months)      67       79    ",
    "scheduleoffutureminimumrentalpaymentforoperatingleasestabletextblock": "      For the year ending December 31:     Operating Lease Payments       2023     $1,327       2024      1,327       2025      1,395       2026      1,429       2027      1,429       Thereafter      805       Total future operating lease payments      7,712       Less: imputed interest      (1,328)      Present value of future minimum lease payments     $6,384   ",
    "issuanceofstockoptionsandrestrictedstockunitstoemployeesanddirectorstabletextblock": "            For the Years Ended  December 31,             2022      2021       RSUs     $1,272      $4,520       Stock options      5,416       5,842       Total     $6,688      $10,362    ",
    "scheduleofweightedaveragedilutivecommonsharetabletextblock": "            December 31,             2022      2021       Stock options issued and outstanding      1,828,329       1,356,639       Restricted stock units issued and outstanding      486,338       383,119       Conversion of Series 1 Convertible Preferred Stock      8,029,039       8,029,039       Total potentially dilutive shares      10,343,706       9,768,797   ",
    "restrictedcashandcashequivalentsnoncurrent": 745000,
    "restrictedcashandcashequivalents": 24872000,
    "propertyplantandequipmentusefullife": 7,
    "shorteroftheusefullifeofassetortheleaseterm": "Shorter of the useful life of asset or the lease term",
    "moneymarketfundsatcarryingvalue": 13284000,
    "availableforsaledebtsecuritiesaccumulatedgrossunrealizedgainbeforetax": 2523000,
    "restrictedcashandinvestments": 745000,
    "marketablesecurities": 78129000,
    "assetsfairvaluedisclosure": 94681000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 78817000,
    "unrealizedloss": -688000,
    "estimatedfairvalue": 78129000,
    "interestincomeother": 2230000,
    "investmentincomenetamortizationofdiscountandpremium": -1137000,
    "realizedinvestmentgainslosses": 17000,
    "investmentincomenet": 1110000,
    "prepaidinsurance": 288000,
    "otherresearchanddevelopmentexpense": 569000,
    "prepaidsoftware": 122000,
    "accruedinterestonmarketabledebtsecurities": 486000,
    "otherprepaidexpensecurrent": 184000,
    "otherassetscurrent": 127000,
    "propertyplantandequipmentgross": 2075000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 483000,
    "accruedemployeerelatedcurrent": 2543000,
    "accruedresearchanddevelopmentcurrent": 512000,
    "otheraccruedliabilitiescurrent": 182000,
    "otherexpenses": 3237000,
    "operatingleasecost": 1366000,
    "shorttermleasecost": 3000,
    "leasecost": 1369000,
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "operatingleaseweightedaverageremainingleaseterm1": 67,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1395000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1429000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1429000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 805000,
    "operatingleasesfutureminimumpaymentdue": 7712000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1328000,
    "presentvalueoffutureminimumleasepayments": 6384000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 844400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.13,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 246977,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 15.35,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 6.9,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.042300000000000004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1828329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 14.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodterm2": 8.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodterm": 8.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1828329,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 14.23,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 755234,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalueexercisable": 18.71,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualtermyearsexercisable": 7.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 125733,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 25.4,
    "deferredfederalincometaxexpensebenefit": -7954000,
    "deferredstateandlocalincometaxexpensebenefit": -1068000,
    "deferredincometaxexpensebenefit": -9022000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 9022000,
    "deferredtaxassetsoperatinglosscarryforwards": 26768000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 3418000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2477000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 3710000,
    "deferredtaxassetsoperatingleaseliability": 1481000,
    "deferredtaxassetsrestrictedstockunitsexpense": 2199000,
    "deferredtaxassetsother": 408000,
    "deferredtaxassetsgross": 40461000,
    "deferredtaxassetsvaluationallowance": 38983000,
    "deferredtaxassetsnet": 1478000,
    "deferredtaxliabilitiesoperatingrightofuseasset": 1456000,
    "deferredtaxliabilitiesother": -22000,
    "deferredincometaxliabilities": 1478000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.022000000000000002,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.033,
    "effectiveincometaxratereconciliationprioryearincometaxes": -0.006999999999999999,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": -0.003,
    "effectiveincometaxratereconciliationsharebasedcompensationcost": 0.001,
    "effectiveincometaxratereconciliationnondeductibleexpenseimpairmentlosses": 0.10400000000000001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.17,
    "netincomelossavailabletocommonstockholdersbasic": 65952000,
    "incomelossfromcontinuingoperationsperbasicshare": -5.86,
    "stockoptionsissuedandoutstanding": 1828329,
    "restrictedstockunitsissuedandoutstanding": 486338,
    "conversionofseries1convertiblepreferredstock": 8029039,
    "totalpotentiallydilutiveshares": 10343706,
    "operatingsegmentdescription": "the Company has determined it operates and manages its business in a single reportable operatingsegment",
    "marketcapitalizationspercentagechange": 0.6,
    "microcapcompaniesmarketcapitalization": 250000000,
    "vestingperiod": "four years",
    "stockoptionperiod": "four years",
    "percentageoflargestamountofbenefit": 0.5,
    "netinvestmentincome": 17000,
    "unrealizedlosses": 358000,
    "totalpropertyandequipmentnet": 1,
    "restrictedcashnoncurrents": 745000,
    "increasedecreaseinoperatingliabilities": 1327000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 6549000,
    "researchanddevelopmentexpenses": 17000,
    "conversionofstocksharesissued1": 1000,
    "preferredstockconvertibleconversionprice": 7.01,
    "commonstockissuanceandoutstandingpercentage": 0.0999,
    "increaseordecreaseequitypercentage": 0.1999,
    "preferredstockliquidationpreference": 10,
    "stocksissuedduringperiodvaluenewissues": 600000,
    "sharesavailableforissuance": 32062,
    "numbersharesauthorized": 32062,
    "unamortizedvalueofrsus": 1412000,
    "weightedaverageremainingamortizationperiod": 1.53,
    "numberofsharesrestrictedstock": 289500,
    "connectionwiththenetsharesettlement": 90000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 4.8,
    "sharebasedcompensationunrecognized": 8333000,
    "netamountatriskbyproductandguaranteeweightedaverageperiodremaining1": 2.5,
    "effectivetaxratedescription": "For the year ended December31, 2022, the Company’s effective tax rate was 0%, which consisted principally of a federal rate of 21%, the Company’s estimateof state taxes, net of federal benefit, of 2.2%, research and development credits of 3.3% and a true-up to the prior year’s taxreturn of 0.7%, offset by goodwill impairment of 10.4% and a valuation allowance 17.0%.",
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 114800000,
    "incometaxcarriedforwardterms": 20,
    "deferredtaxassetsothertaxcarryforwards": 114200000,
    "employeecontributions": 1,
    "employeecompensation": 0.04,
    "otherlaborrelatedexpenses": 223000,
    "entityregistrantname": "Protara Therapeutics, Inc.",
    "tradingsymbol": "TARA",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1359931,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36694",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "20-4580525",
    "entityaddressaddressline1": "345 Park Avenue South",
    "entityaddressaddressline2": "3rd Floor",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(646)",
    "localphonenumber": "844-0337",
    "security12btitle": "common stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "New York, New York"
  },
  {
    "date": "2021-12-30",
    "symbol": "TARA",
    "period": "FY",
    "cashandcashequivalentsatcarryingvalue": 35724000,
    "marketablesecuritiescurrent": 55505000,
    "prepaidexpenseandotherassetscurrent": 1883000,
    "assetscurrent": 93112000,
    "restrictedcashnoncurrent": 745000,
    "marketablesecuritiesnoncurrent": 39467000,
    "propertyplantandequipmentnet": 1719000,
    "operatingleaserightofuseasset": 7171000,
    "goodwill": 29517000,
    "otherassetsnoncurrent": 865000,
    "assets": 172596000,
    "accountspayablecurrent": 954000,
    "accruedliabilitiescurrent": 2489000,
    "operatingleaseliabilitycurrent": 855000,
    "liabilitiescurrent": 4298000,
    "operatingleaseliabilitynoncurrent": 6384000,
    "liabilities": 10682000,
    "commonstockvalue": 11000,
    "additionalpaidincapital": 256126000,
    "retainedearningsaccumulateddeficit": -94012000,
    "accumulatedothercomprehensiveincomelossnetoftax": -211000,
    "stockholdersequity": -211000,
    "liabilitiesandstockholdersequity": 172596000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 8028,
    "preferredstocksharesissued": 8027,
    "preferredstocksharesoutstanding": 8027,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 23891,
    "commonstocksharesoutstanding": 11235731,
    "researchanddevelopmentexpense": 21088000,
    "generalandadministrativeexpense": 26401000,
    "operatingexpenses": 47489000,
    "operatingincomeloss": -47489000,
    "investmentincomeinterest": 237000,
    "nonoperatingincomeexpense": 237000,
    "profitloss": -47252000,
    "earningspersharebasicanddiluted": -4.21,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 11232576,
    "othercomprehensiveincomeunrealizedholdinggainlossonsecuritiesarisingduringperiodnetoftax": -211000,
    "othercomprehensiveincomelossnetoftax": -211000,
    "comprehensiveincomenetoftax": -47463000,
    "sharesoutstanding": 11235731,
    "settlementofrestrictedstockunits": -228000,
    "settlementofrestrictedstockunitinshares": 23891,
    "stockissuedduringperiodvaluesharebasedcompensation": 10362000,
    "othercomprehensiveincomelossbeforetax": -211000,
    "netincomeloss": -47252000,
    "sharebasedcompensation": 8953000,
    "operatingleaserightofuseassetamortizationexpense": 1050000,
    "depreciation": 81000,
    "amortizationofdiscountsandpremiumsinvestments": 1737000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 418000,
    "increasedecreaseinotheroperatingassets": -295000,
    "increasedecreaseinaccountspayable": 40000,
    "increasedecreaseinaccruedliabilities": 576000,
    "increasedecreaseinotheroperatingliabilities": -1009000,
    "netcashprovidedbyusedinoperatingactivities": -34502000,
    "paymentstoacquireavailableforsalesecuritiesdebt": 124748000,
    "proceedsfrommaturityandredemptionofmarketabledebtsecurities": 27150000,
    "paymentstoacquirepropertyplantandequipment": 596000,
    "netcashprovidedbyusedininvestingactivities": -98194000,
    "paymentsforrepurchaseofcommonstock": 228000,
    "netcashprovidedbyusedinfinancingactivities": -228000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": -132924000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 36469000,
    "marketabledebtsecuritiestextblock": "5. Marketable Debt Securities ",
    "leasesoflessordisclosuretextblock": "10. Leases ",
    "marketabledebtsecuritiespolicytextblock": "Marketable Debt Securities ",
    "patentcostspolicytextblock": "Patent Costs ",
    "recentaccountingpronouncementsnotyetadopted": "Recent Accounting Pronouncements NotYet Adopted ",
    "scheduleofestimatedusefullivesforsignificantpropertyandequipmenttabletextblock": "      Asset Classification         Estimated Useful Life      Computer equipment         5      Furniture, fixtures and other         5      Laboratory equipment         7      Leasehold improvements         Shorter of the useful life of asset or the lease term    ",
    "scheduleofcomponentsofinvestmentincometabletextblock": "            December 31,             2021      2020       Interest income     $1,974      $500       Accretion/(amortization) of discount/premium, net      (1,737)      -       Total interest and investment income     $237      $500   ",
    "scheduleofotherinformationrelatedtoleasestabletextblock": "            For the year ended December 31,             2021      2020                            Weighted-average discount rate      7.0%      12.0%      Weighted-average remaining lease term – operating lease (in months)      79       87    ",
    "scheduleoffutureminimumrentalpaymentforoperatingleasestabletextblock": "      For the year ending December 31:     Operating Lease Payments       2022     $1,327       2023      1,327       2024      1,327       2025      1,395       2026      1,429       Thereafter      2,234       Total gross operating lease payments      9,039       Less: imputed interest      (1,800)      Total lease liabilities, reflecting present value of future minimum lease payments     $7,239   ",
    "issuanceofstockoptionsandrestrictedstockunitstoemployeesanddirectorstabletextblock": "            For the Years Ended December 31,             2021      2020       RSUs     $4,520      $6,357       Stock options      5,842       3,389       Total     $10,362      $9,746    ",
    "scheduleofweightedaveragedilutivecommonsharetabletextblock": "            December 31,             2021      2020       Stock options issued and outstanding      1,356,639       674,039       Restricted stock units issued and outstanding      383,119       407,325       Conversion of Series 1 Convertible Preferred Stock      8,029,039       8,029,039       Total potentially dilutive shares      9,768,797       9,110,403   ",
    "restrictedcashnoncurrents": 745000,
    "restrictedcashandcashequivalents": 36469000,
    "propertyplantandequipmentusefullife": 7,
    "leaseholdimprovements": "Shorter of the useful life of asset or the lease term",
    "businessacquisitionsproformanetincomeloss": -33754000,
    "proformalosspercommonsharebasicanddiluted": -4.62,
    "proformaweightedaveragenumberofcommonsharesoutstandingbasicanddiluted": 7304201,
    "cashandcashequivalentsfairvaluedisclosure": 26323000,
    "restrictedcashandcashequivalentsnoncurrent": 745000,
    "marketablesecurities": 94972000,
    "assetsfairvaluedisclosure": 122040000,
    "availableforsaledebtsecuritiesamortizedcostbasis": 95183000,
    "unrealizedlosses": 211000,
    "estimatedfairvalue": 94972000,
    "interestincomeother": 1974000,
    "investmentincomenetamortizationofdiscountandpremium": -1737000,
    "investmentincomenet": 237000,
    "prepaidinsurance": 279000,
    "otherresearchanddevelopmentexpense": 684000,
    "prepaidsoftware": 79000,
    "accruedinterestonmarketabledebtsecurities": 634000,
    "otherprepaidexpensecurrent": 173000,
    "otherassetscurrent": 34000,
    "propertyplantandequipmentgross": 1955000,
    "propertyplantandequipmentother": 613000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 236000,
    "accruedemployeerelatedcurrent": 1801000,
    "accruedpayrolltaxescurrent": 41000,
    "legalfeesofaccruedexpenses": 29000,
    "accruedresearchanddevelopmentcurrent": 437000,
    "otheraccruedliabilitiescurrent": 181000,
    "operatingleasecost": 1050000,
    "shorttermleasecost": 102000,
    "leasecost": 1152000,
    "operatingleaseweightedaveragediscountratepercent": 0.07,
    "operatingleaseweightedaverageremainingleaseterm1": 79,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1327000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1395000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1429000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 2234000,
    "operatingleasesfutureminimumpaymentdue": 9039000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1800000,
    "presentvalueoffutureminimumleasepayments": 7239000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 96201,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 28.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 861850,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 16.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 168196,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 17.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 188915,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 12.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 19.82,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.98,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.013300000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1356639,
    "weightedaverageexercisepricebalance": 20.51,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": 9.06,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 1000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodterm2": 8.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 1356639,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 20.51,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 407981,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalueexercisable": 21.97,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualtermyearsexercisable": 7.83,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 11054,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 26.15,
    "deferredfederalincometaxexpensebenefit": -8918000,
    "deferredstateandlocalincometaxexpensebenefit": 4294000,
    "deferredincometaxexpensebenefit": -4624000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 4624000,
    "deferredtaxassetsoperatinglosscarryforwards": 23350000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 920000,
    "deferredtaxassetsinprocessresearchanddevelopment": 1551000,
    "deferredtaxassetsoperatingleaseliability": 1564000,
    "deferredtaxassetsrestrictedstockunitsexpense": 1960000,
    "deferredtaxassetsother": 7000,
    "deferredtaxassetsgross": 29352000,
    "deferredtaxassetsvaluationallowance": 27803000,
    "deferredtaxassetsnet": 1549000,
    "deferredtaxliabilitiesoperatingrightofuseasset": 1549000,
    "deferredincometaxliabilities": 1549000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": -0.006,
    "effectiveincometaxratereconciliationtaxcreditsresearch": -0.033,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.011000000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.012,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.08199999999999999,
    "effectiveincometaxratereconciliationotheradjustments": 0.015,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.129,
    "netincomelossavailabletocommonstockholdersbasic": 47252000,
    "incomelossfromcontinuingoperationsperbasicanddilutedshare": -4.21,
    "stockoptionsissuedandoutstanding": 1356639,
    "restrictedstockunitsissuedandoutstanding": 383119,
    "conversionofseries1convertiblepreferredstock": 8029039,
    "totalpotentiallydilutiveshares": 9768797,
    "goodwillfairvaluedisclosure": 29500000,
    "percentageoflargestamountofbenefit": 0.5,
    "stockholdersequityreversestocksplit": "On January 9, 2020, in connection with, and priorto the completion of the Merger, Protara Therapeutics, Inc. effected the Protara Reverse Stock Split, which resulted in 557,631 pre-mergershares of Protara Therapeutics, Inc. outstanding. ",
    "convertibleconversionratio1": 0.190756,
    "commonstockothersharesoutstanding": 2627533,
    "sharesavailableforissuance": 20365,
    "conversionofstocksharesissued1": 1000,
    "convertiblepreferredstocksharesissueduponconversion": 10,
    "premergershares": 557631,
    "reversebusinesscombination": 1033907,
    "descriptionofownershiprights": "Immediately after the consummation of the Mergerand prior to the consummation of the Proteon Private Placement, the former stockholders and option holders of Private ArTara owned, orheld rights to acquire, approximately 75.2% of the fully diluted common stock of Protara, with Protara Therapeutics, Inc.’s stockholdersand option holders immediately prior to the Merger owning approximately 24.8% of the fully-diluted common stock of Protara. ",
    "deferredtaxliabilitiesprepaidexpenses": 78000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 77000,
    "fairvalueofnetassets": 34533000,
    "totalpropertyandequipmentnet": 1,
    "increasedecreaseinoperatingliabilities": 1009000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 6549000,
    "researchanddevelopmentexpenses": 15000,
    "debtinstrumentconvertibleconversionprice1": 7.01,
    "commonstockissuanceandoutstandingpercentage": 0.0999,
    "increaseordecreaseequitypercentage": 0.1999,
    "stocksissuedduringperiodvaluenewissues": 600000,
    "numbersharesauthorized": 25037,
    "unamortizedvalueofrsus": 1835000,
    "weightedaverageremainingamortizationperiod": 2.39,
    "numberofsharesrestrictedstock": 286918,
    "netsettlement": 34706000,
    "connectionwiththenetsharesettlement": 228000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaverageexpecteddividend": 12664000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 2.71,
    "deferredtaxassetsoperatinglosscarryforwardssubjecttoexpiration": 29600000,
    "incometaxcarriedforwardterms": 20,
    "deferredtaxassetsothertaxcarryforwards": 99600000,
    "valuationallowancedeferredtaxassetchangeinamount": 27800000,
    "descriptionofdefinedcontributionpensionandotherpostretirementplans": "The Company maintains a defined contribution benefitplan under section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the “401(k)Plan”). Under the 401(k) Plan, the Company matches 100% up to a 4% contribution. The 401(k) Plan was implemented in June of 2020.For the years ended December 31, 2021 and 2020, the Company recorded expense of $215 and $69, respectively, representing employer contributionsunder the 401(k) Plan.",
    "entityregistrantname": "Protara Therapeutics, Inc.",
    "tradingsymbol": "TARA",
    "documenttype": "10-K",
    "currentfiscalyearenddate": "December 31",
    "amendmentflag": "false",
    "entitycentralindexkey": 1359931,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "No",
    "icfrauditorattestationflag": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-36694",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "20-4580525",
    "entityaddressaddressline1": "345 Park Avenue South",
    "entityaddressaddressline2": "3rd Floor",
    "entityaddresspostalzipcode": 10010,
    "cityareacode": "(646)",
    "localphonenumber": "844-0337",
    "security12btitle": "common stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "entityinteractivedatacurrent": "Yes",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young LLP",
    "auditorlocation": "New York, New York",
    "entityaddresscityortown": "New York",
    "entityaddressstateorprovince": "NY"
  },
  {
    "date": "2020-12-30",
    "symbol": "TARA",
    "period": "FY",
    "entityregistrantname": "Protara Therapeutics, Inc.",
    "entitycentralindexkey": 1359931,
    "amendmentflag": "false",
    "documenttype": "10-K",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "documentperiodenddate": "2020-12-31",
    "entitycurrentreportingstatus": "Yes",
    "currentfiscalyearenddate": "--12-31",
    "entityfilenumber": "001-36694",
    "entityincorporationstatecountrycode": "DE",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "cashandcashequivalentsatcarryingvalue": 168598000,
    "restrictedcashcurrent": 50000,
    "prepaidexpenseandotherassetscurrent": 787000,
    "assetscurrent": 169435000,
    "restrictedcashandinvestments": 745000,
    "propertyplantandequipmentnet": 1240000,
    "goodwill": 29517000,
    "otherassetsnoncurrent": 2220000,
    "assets": 203157000,
    "accountspayablecurrent": 914000,
    "accruedliabilitiescurrent": 1913000,
    "operatingleaseliabilitycurrent": 88000,
    "liabilitiescurrent": 2915000,
    "operatingleaseliabilitynoncurrent": 999000,
    "liabilities": 3914000,
    "commonstockvalue": 11000,
    "additionalpaidincapital": 245992000,
    "retainedearningsaccumulateddeficit": -46760000,
    "stockholdersequity": -46760000,
    "liabilitiesandstockholdersequity": 203157000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 8028,
    "preferredstocksharesissued": 8027,
    "preferredstocksharesoutstanding": 8027,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 18012,
    "commonstocksharesissued": 13340,
    "commonstocksharesoutstanding": 11211840,
    "researchanddevelopmentexpense": 11982000,
    "generalandadministrativeexpense": 22462000,
    "operatingexpenses": 34444000,
    "operatingincomeloss": -34444000,
    "interestincomeexpensenet": 466000,
    "nonoperatingincomeexpense": 466000,
    "netincomeloss": -33978000,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 7233913,
    "earningspersharebasicanddiluted": -4.7,
    "sharesoutstanding": 11211840,
    "issuanceofcommonstockinartaraprivateplacementnetofofferingcosts": 1867000,
    "issuanceofcommonstockinartaraprivateplacementnetofofferingcostsshares": 284875,
    "stockissuedduringperiodvalueother": 12411000,
    "stockissuedduringperiodsharesother": 1896888,
    "issuanceofseries1convertiblepreferredstockinproteonprivateplacementnetofofferingcosts": 25319000,
    "issuanceofseries1convertiblepreferredstockinproteonprivateplacementnetofofferingcostsshares": 3879,
    "stockissuedduringperiodvalueacquisitions": 34532000,
    "stockissuedduringperiodsharesacquisitions": 1033907,
    "stockissuedduringperiodvalueissuedforservices": 73566000,
    "stockissuedduringperiodsharesissuedforservices": 4600000,
    "stockissuedduringperiodvalueissuanceofseries1convertiblepreferredstocknetofofferingcosts": 66284000,
    "stockissuedduringperiodsharesissuanceofseries1convertiblepreferredstocknetofofferingcosts": 4148,
    "stockissuedduringperiodvaluenewissues": 11086000,
    "stockissuedduringperiodsharesnewissues": 690000,
    "stockissuedduringperiodsharesissuedforsettlementofrestrictedstockunits": 20870,
    "stockissuedduringperiodvaluestockoptionsexercised": 530000,
    "stockissuedduringperiodsharesstockoptionsexercised": 57767,
    "adjustmentstoadditionalpaidincapitalother": 6357000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3389000,
    "profitloss": -33978000,
    "sharebasedcompensation": 9005000,
    "amortizationofoperatingleaserightsofuseasset": 93000,
    "depreciation": 4000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1405000,
    "increasedecreaseinothernoncurrentassets": -58000,
    "increasedecreaseinaccountspayable": 198000,
    "increasedecreaseinaccruedliabilities": -966000,
    "increasedecreaserightofuseliability": 66000,
    "netcashprovidedbyusedinoperatingactivities": -23407000,
    "cashandrestrictedcashacquiredinconnectionwithreversemergerwithartaratherapeuticsinc.": 3719000,
    "paymentstoacquirepropertyplantandequipment": 884000,
    "netcashprovidedbyusedininvestingactivities": 2835000,
    "proceedsfromissuanceinitialpublicoffering": 1867000,
    "proceedsfromproteonprivateplacementnetofofferingcosts": 12413000,
    "proceedsfromissuanceofconvertiblepreferredstock": 25319000,
    "proceedsfromissuancesofconvertiblepreferredstock": 73570000,
    "proceedsfromissuanceofcommonstock": 66284000,
    "proceedsfromunderwritersoverallotmentoption": 11087000,
    "repaymentsofshorttermdebt": 1669000,
    "proceedsfromstockoptionsexercised": 530000,
    "netcashprovidedbyusedinfinancingactivities": 189401000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseexcludingexchangerateeffect": 168829000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 169393000,
    "restrictedcashnoncurrent": 745000,
    "reconciliationofrestrictedcashandcashequivalents": 169393000,
    "interestpaidnet": 34000,
    "deferredofferingcostsrecognizedthatwerepreviouslyrecordedinaccruedexpenses": 122000,
    "purchaseofinsuranceagreementwithnotespayable": 1669000,
    "commonstockissuedinconnectionwithreversemerger": 34533000,
    "workingcapital": 166520000,
    "netofofferingcosts": 39600000000,
    "proceedsfrompublicofferinggross": 42500000000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 8029039,
    "cashcollateralforborrowedsecurities": 795000,
    "goodwillwrittenoffrelatedtosaleofbusinessunit": 150000000,
    "restrictcash": 795000,
    "assetsacquiredandliabilitiesassumedcash": 3669000,
    "assetsacquiredandliabilitiesassumedrestrictedcash": 50000,
    "assetsacquiredandliabilitiesassumedprepaidexpensesandotherassets": 1662000,
    "assetsacquiredandliabilitiesassumedgoodwill": 29517000,
    "assetsacquiredandliabilitiesassumedaccruedexpenses": 365000,
    "assetsacquiredandliabilitiesassumedtotalpurchaseprice": 34533000,
    "businessacquisitionsproformanetincomeloss": -33754000,
    "proformalosspercommonsharebasicanddiluted": -4.62,
    "proformaweightedaveragenumberofcommonsharesoutstandingbasicanddiluted": 7304201,
    "stockholdersequityreversestocksplit": "On January 9, 2020, in connection with, and prior to the completion of the Merger, Protara Therapeutics, Inc. effected the Protara Reverse Stock Split, which resulted in 557,631 pre-merger shares of Protara Therapeutics, Inc. outstanding.",
    "sharesavailableforissuance": 227850,
    "conversionofstocksharesissued1": 1000,
    "convertiblepreferredstocksharesissueduponconversion": 476276,
    "fairvalueofnetassets": 34533000,
    "descriptionofownershiprights": "Immediately after the consummation of the Merger and prior to the consummation of the Proteon Private Placement, the former stockholders and option holders of Private ArTara owned, or held rights to acquire, approximately 75.2% of the fully-diluted Common Stock of Protara, with Protara Therapeutics, Inc.'s stockholders and option holders immediately prior to the Merger owning approximately 24.8% of the fully-diluted Common Stock of Protara.",
    "premergershares": 557631,
    "reversebusinesscombination": 1033907,
    "deferredtaxliabilitiesprepaidexpenses": 78000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 77000,
    "propertyplantandequipmentother": 503000,
    "propertyplantandequipmentgross": 200000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 119000,
    "propertyplantandequipmentusefullife": "P5Y",
    "accruedemployeebenefitscurrent": 1530000,
    "accruedpayrolltaxescurrent": 159000,
    "legalfeesofaccruedexpenses": 156000,
    "deferredtaxliabilitiesdeferredexpensecapitalizedresearchanddevelopmentcosts": 37000,
    "otheraccruedliabilitiescurrent": 31000,
    "interestexpense": 34000,
    "operatingleaserightofuseasset": 999000,
    "operatingleasecost": 93000,
    "shorttermleasecost": 215000,
    "leasecost": 308000,
    "operatingleaseweightedaveragediscountratepercent": 0.12,
    "operatingleaseweightedaverageremainingleaseterm1": "P87M",
    "operatingleasesfutureminimumpaymentsremainderoffiscalyear": 1111000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 1333000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 1338000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 1342000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 1423000,
    "operatingleasesfutureminimumpaymentsduethereafter": 3277000,
    "operatingleasesfutureminimumpaymentsdue": 9824000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 8676000,
    "operatingleaseliability": 1148000,
    "presentvalueoffutureminimumleasepaymentsforouroperatingleaseliabilities": 1087000,
    "presentvalueoffutureminimumleasepaymentsshorttermleases": 61000,
    "researchanddevelopmentexpenses": 30000,
    "sharesissuedpricepershare": 10,
    "increaseordecreaseequitypercentage": 0.1999,
    "debtinstrumentconvertibleconversionprice1": 7.01,
    "saleofstockpricepershare": 51.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 565100,
    "commonstockissuanceandoutstandingpercentage": 0.0999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestednumberofshares": 274616,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 52886,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestednumberofshares": 148334,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalue": 10867,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 22.61,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedoptionsforfeitedweightedaveragegrantdatefairvalue": 14.08,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedweightedaveragegrantdatefairvalue": 30,
    "stockoptionexerciseprice": 17.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexerciseprice": 17.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.95,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y3M8D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 674039,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumberexercisable": 109117,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisedinperiodweightedaveragegrantdatefairvalue": 6.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsnonvestedweightedaveragegrantdatefairvalueexercisable": 11.44,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 25.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 29.23,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.18,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexercisepriceexercisable": 15.63,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodterm1": "P9Y8M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodterm2": "P9Y0M22D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsweightedaverageremainningperiodtermexercisable": "P8Y2M30D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueoutstanding": 2311000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsaggregateintrinsicvalueexercisable": 1201000,
    "stocksissuedduringperiodvaluenewissues": 484850000,
    "vestedoptionspercentage": 0.25,
    "unamortizedvalueofrsus": 6299000,
    "numberofsharesrestrictedstock": 132709,
    "weightedaverageremainingamortizationperiod": "P3Y0M0D",
    "unamortizedvalueofstock": 9973000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 62000,
    "otherresearchanddevelopmentexpense": 152000,
    "incrementalvalue": 501000,
    "vestperiod": "P10Y0M0D",
    "deferredfederalincometaxexpensebenefit": -6211000,
    "deferredstateandlocalincometaxexpensebenefit": -2439000,
    "deferredothertaxexpensebenefit": -8650000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 8650000,
    "deferredtaxassetsotherlosscarryforwards": 19371000,
    "deferredtaxassetsorganizationcostslegalfees": 8000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefits": 443000,
    "deferredtaxassetsinprocessresearchanddevelopment": 70000,
    "deferredtaxassetsoperatingleaseliability": 330000,
    "restrictedstockunitsexpense": 1796000,
    "deferredtaxassetscharitablecontributions": 2000,
    "deferredtaxassetsgross": 22020000,
    "deferredtaxassetsvaluationallowance": 21698000,
    "deferredtaxassetsnet": 322000,
    "deferredtaxliabilitiesoperatingrightofuseasset": -322000,
    "deferredtaxliabilitiestaxdeferredincome": 322000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.094,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.012,
    "effectiveincometaxratereconciliationnondeductibleexpenseother": 0.019,
    "effectiveincometaxratereconciliationprioryearincometaxes": 0.018,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": 0.255,
    "deferredtaxassetsoperatinglosscarryforwards": 63700000,
    "valuationallowancedeferredtaxassetchangeinamount": 21700000,
    "netoperatinglossafterapplication": 1400000,
    "descriptionofdefinedcontributionpensionandotherpostretirementplans": "The Company maintains a defined contribution benefit plan under section 401(k) of the Internal Revenue Code covering substantially all qualified employees of the Company (the \"401(k) Plan\"). Under the 401(k) Plan, the Company matches 100% up to a 4% contribution.",
    "otherexpenses": 69000
  },
  {
    "date": "2019-12-30",
    "symbol": "TARA",
    "period": "FY",
    "entityregistrantname": "ArTara Therapeutics, Inc.",
    "entitycentralindexkey": 1359931,
    "tradingsymbol": "tara",
    "currentfiscalyearenddate": "--12-31",
    "entityfilercategory": "Non-accelerated Filer",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entitywellknownseasonedissuer": "No",
    "entityemerginggrowthcompany": "false",
    "entitysmallbusiness": "true",
    "entityinteractivedatacurrent": "Yes",
    "entityshellcompany": "false",
    "documenttype": "10-K",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "amendmentflag": "false",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 22000,
    "preferredstocksharesissued": 18954,
    "preferredstocksharesoutstanding": 18954,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 100000000,
    "commonstocksharesissued": 557631,
    "commonstocksharesoutstanding": 557631,
    "severancecosts1": 2900000,
    "cashcashequivalentsandshortterminvestments": 6200000,
    "retainedearningsaccumulateddeficit": -225462000,
    "numberofoperatingsegments": 1,
    "numberofreportablesegments": 1,
    "depreciation": 279000,
    "impairmentoflonglivedassetsheldforuse": 200000,
    "certificatesofdepositatcarryingvalue": 50000,
    "conversionofstocksharesissued1": 76540,
    "conversionofstocksharesconverted1": 3046,
    "preferredstockliquidationpreference": 0.001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 17600,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofannualadditionalsharespercentage": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P36D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 29563,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 80,
    "commonstockcapitalsharesreservedforfutureissuance": 664961,
    "allocatedsharebasedcompensationexpense": 943000,
    "valuationallowancedeferredtaxassetchangeinamount": 2400000,
    "operatinglosscarryforwards": 37200000,
    "operatinglosscarryforwardsnetindefinitelived": 30600000,
    "taxcreditcarryforwardamount": 3600000,
    "propertyplantandequipmentusefullife": "P7Y",
    "researchanddevelopmentexpense": 6438000,
    "generalandadministrativeexpense": 8816000,
    "operatingexpenses": 15254000,
    "operatingincomeloss": -15254000,
    "investmentincomenet": 262000,
    "nonoperatingincomeexpense": 262000,
    "netincomeloss": -14992000,
    "othercomprehensiveincomeforeigncurrencytransactionandtranslationadjustmentnetoftaxportionattributabletoparent": -2000,
    "comprehensiveincomenetoftax": -14994000,
    "earningspersharebasicanddiluted": -30.15,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 497275,
    "accretionamortizationofdiscountsandpremiumsinvestments": 4000,
    "sharebasedcompensation": 943000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -608000,
    "increasedecreaseinoperatingleaserightofuseassets": -200000,
    "increasedecreaseinotherreceivables": -17000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -2497000,
    "increasedecreaseinoperatingleaseliabilities": -200000,
    "netcashprovidedbyusedinoperatingactivities": -15646000,
    "proceedsfrommaturitiesprepaymentsandcallsofavailableforsalesecurities": 2500000,
    "paymentstoacquirepropertyplantandequipment": 16000,
    "netcashprovidedbyusedininvestingactivities": 2484000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -13162000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 6231000,
    "sharesoutstanding": 557631,
    "stockholdersequity": 6392000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 943000,
    "othercomprehensiveincomelossnetoftaxportionattributabletoparent": -2000,
    "conversionofstockamountconverted1": 3060000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 76540,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": 3060000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsweightedaveragevolatilityrate": 0.896,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y36D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.026,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 218.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P36D",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 106.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 80431,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 124.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 63951,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 260.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 218.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 111,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 218.4,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P36D",
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -14965000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -27000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -14992000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3148000,
    "effectiveincometaxratereconciliationnondeductibleexpenseexcludingstockcompensation": 1000,
    "effectiveincometaxratereconciliationwriteoffofdeferredtaxassetamount": 2048000,
    "incometaxreconciliationstateincometaxesnetoffederalbenefit": -930000,
    "incometaxreconciliationtaxcredits": 465000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 2449000,
    "incometaxreconciliationforeignincometaxratedifferential": 5000,
    "incometaxreconciliationotheradjustments": 40000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 476390,
    "restructuringcharges": 2854000,
    "paymentsforrestructuring": 2854000,
    "cashandcashequivalentsatcarryingvalue": 6181000,
    "restrictedcashcurrent": 50000,
    "prepaidexpenseandotherassetscurrent": 744000,
    "assetscurrent": 6975000,
    "assets": 6975000,
    "accountspayablecurrent": 263000,
    "accruedliabilitiescurrent": 320000,
    "liabilitiescurrent": 583000,
    "liabilities": 583000,
    "preferredstockvalue": 18463000,
    "additionalpaidincapital": 213388000,
    "accumulatedothercomprehensiveincomelossnetoftax": 3000,
    "liabilitiesandstockholdersequity": 6975000,
    "employeerelatedliabilitiescurrent": 4000,
    "contractedservicecosts": 9000,
    "accruedprofessionalfeescurrent": 307000,
    "deferredtaxassetsoperatinglosscarryforwards": 11090000,
    "deferredtaxassetstaxcreditcarryforwardsgeneralbusiness": 3587000,
    "deferredtaxassetsgoodwillandintangibleassets": 74000,
    "deferredtaxassetsother": 59000,
    "deferredtaxassetsgross": 14810000,
    "deferredtaxassetsvaluationallowance": 14810000,
    "cashandcashequivalentsfairvaluedisclosure": 5841000,
    "assetsfairvaluedisclosure": 5841000
  }
]